REGN vs SELF · P/E 14, rev $14.34B vs P/E 30, rev $12.5M
Regeneron Pharmaceuticals Inc (REGN) versus Global Self Storage Inc (SELF) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Global Self Storage Inc (SELF) is a reit - specialty company listed on NASDAQ.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported SELF revenue for 2024-12-31 was $12.5M. Net income was $2.1M. Revenue was up 2.8% from 2023-12-31 to 2024-12-31. SELF currently screens at market cap $58.3M and trailing P/E 30.0.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. SELF currently screens at market cap $58.3M and trailing P/E 30.0.
Not investment advice. Open the REGN and SELF stock pages for the full models.
Not investment advice.